Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani

NCT: NCT07311876 · NOT_YET_RECRUITING

NCT IDNCT07311876
StatusNOT_YET_RECRUITING
Start Date2026-04-28
Completion2027-10-28

Brief Summary

The objective of this study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during open lymphatic reconstruction in the head and neck.

Frequently Asked Questions

What is Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani?

Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani is a clinical trial registered under NCT07311876. Current status: NOT_YET_RECRUITING.

What is the status of NCT07311876?

The current status of NCT07311876 (Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani) is: NOT_YET_RECRUITING.

When did Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani start?

Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani started on 2026-04-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑